A Minimal PBPK/PD Model with Expansion-Enhanced Target-Mediated Drug Disposition to Support a First-in-Human Clinical Study Design for a FLT3L-Fc Molecule. - Hosseini, Iraj; Fleisher, Brett; Getz, Jennifer; Decalf, Jérémie; Kwong, Mandy; Ovacik, Meric; Bainbridge, Travis W.; Moussion, Christine; Rao, Gautham K.; Gadkar, Kapil; Kamath, Amrita V.; Ramanujan, Saroja (Pharmaceutics, 2024)